Table 4.
Microorganisms used in microbial fermentation.
| Microorganism | Peptide sequence | Bioactivity | References |
|---|---|---|---|
| Enterococcus faecalis | LVYPFPGPIPNSLPQNIPP, LHLPLP, LHLPLPL, VLGPVRGPFP, VRGPFPIIV | Antihypertensive | (Quirós et al., 2007) |
| Lactococcus lactis NRRL-B-50571 | DDQNPH, LDDDLTDDI, YPSYGL, HPHPHLSFMAIPP, YDTQAIVQ, DDDLTDDIMCV, YPSYG | ACE inhibitory | (Rodríguez-Figueroa et al., 2013) |
| Bifidobacterium bifidum MF 20/5 | LVYPFP | ACE inhibitory | (Gonzalez-Gonzalez, Gibson, & Jauregi, 2013) |
| Lactobacillus helveticus | VPP, IPP | Antihypertensive, antiinflammatory, antiadipogenic, antiatherosclerotic | (Fekete, Ian Givens, & Lovegrove, 2015) |
| Saccharomyces cerevisiae | VPP, IPP | Antihypertensive, antiinflammatory, antiadipogenic, antiatherosclerotic | (Chakrabarti & Wu, 2015) |
| Lacticaseibacillus casei shirota y Streptococcus thermophiles | YQEPVLGPVRGPFPIIV | ACE inhibitory, antithrombotic | (Rojas-Ronquillo et al., 2012) |
| Lactobacillis delbrueckii ssp. bulgaricus, Streptococcus thermophilus | VPYPQ, KAVPYPQ, KVLPVPE, GVRGPFPII, IPIQY, QQPVLGPVRGPFPIIV GVSKVKEAMAPKHKEMPFPKYPVEPFTESQ QEPVL, QEPV |
AntioxidantMucin stimulating, ACE inhibitory, opioidImmunomodulating | (Jiehui et al., 2014) |
| Bacillus licheniformis B1 | LE, EW, SP, VE, VL, VT, EF | Antidiabetic | (Yang et al., 2013) |
| Aspergillus aegypticus | Peptide containing Phe, Ile, and Gly in the ratio 1:2:5 | ACE inhibitory | (Zhang, Tatsumi, Ding, & Li, 2006) |
| Lacticaseibacillus casei spp. pseudoplantarum | LIVTQ, LIVT | ACE inhibitory | (Vallabha & Tiku, 2014) |
| Aspergillus sojae | AW, GW,AY, SY, GY, AF, VP, AI, VG | Antihypertensive | (Nakahara et al., 2011) |
| Lactobacillus sanfranciscensis and Candida humilis | VPFGVG | ACE inhibitory | (Nakamura, Yoshida, Komatsuzaki, Kawasumi, & Shima, 2007) |
| Lactiplantibacillus plantarum LB1; L. rossiae LB5 | VLHEPLF – YNNPIIYVTENGIAEGNNKSLPITEAL – ALKAAPSPA – AILIIVMLFGR – AAAAVFLSLLAVGHCAAADFNATDADADFAG NGVDFNSSDAAVYWGPWTKAR |
Antifungal | (Rizzello, Cassone, Coda, & Gobbetti, 2011) |
| Lactobacillus acidophilus ATCC 4356 | Unidentified | Inmunomodulatory | (Stuknyte, De Noni, Guglielmetti, Minuzzo, & Mora, 2011) |
| Pichia kudriavzevii, K. marxianus | Unidentified | ACE-I inhibition | (Chaves-López et al., 2014) |
| Aspergillus oryzae | VPP, IPP | Antihypertensive | (Inoue et al., 2009) |